CD8⁺GITR⁺ T cells may negatively regulate T cell overactivation in aplastic anemia

References

• Azuma M. 2019. Co-signal molecules in T-cell activation: historical overview and perspective. Adv Exp Med Biol. 1189:3–23.
   PubMedGoogle Scholar
• Boleto G, Allanore Y, Avouac J. 2018. Targeting costimulatory pathways in systemic sclerosis. Front Immunol. 9:2998.
   PubMed Web of Science ®Google Scholar
• Burugu S, Dancsok AR, Nielsen TO. 2018. Emerging targets in cancer immunotherapy. Semin Cancer Biol. 52:39–52.
   PubMed Web of Science ®Google Scholar
• Croft M. 2014. The TNF family in T cell differentiation and function–unanswered questions and future directions. Semin Immunol. 26:183–90.
   PubMed Web of Science ®Google Scholar
• Ford ML, Adams AB, Pearson TC. 2014. Targeting co-stimulatory pathways: transplantation and autoimmunity. Nat Rev Nephrol. 10(1):14–24.
   PubMed Web of Science ®Google Scholar
• Gunavathy N, Asirvatham A, Chitra A, Jayalakshmi M. 2019. Association of CTLA-4 and CD28 gene polymorphisms with type 1 diabetes in South Indian population. Immunol Invest. 48(6):659–71.
   PubMed Web of Science ®Google Scholar
• Haanstra KG, Dijkman K, Bashir N, Bauer J, Mary C, Poirier N, Baker P, Scobie L, ’T Hart BA, Vanhove B, et al. 2015. Selective blockade of CD28-mediated T cell costimulation protects rhesus monkeys against acute fatal experimental autoimmune encephalomyelitis. J Immunol. 194(4):1454–66.
   PubMed Web of Science ®Google Scholar
• Huang C, Zhu H-X, Yao Y, Bian Z-H, Zheng Y-J, Li L, Moutsopoulos HM, Gershwin ME, Lian Z-X. 2019. Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases. J Autoimmun. 104:102333.
   PubMed Web of Science ®Google Scholar
• Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T, Sakaguchi S, et al. 2005. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J Exp Med. 202(7):885–91.
   PubMed Web of Science ®Google Scholar
• Li B, Guo L, Zhang Y, Xiao Y, Wu M, Zhou L, Chen S, Yang L, Lu X, Li Y, et al. 2016. Molecular alterations in the TCR signaling pathway in patients with aplastic anemia. J Hematol Oncol. 9(1):32.
   PubMedGoogle Scholar
• Liu C, Li Z, Sheng W, Fu R, Li L, Zhang T, Wu Y, Xing L, Song J, Wang H, et al. 2014. Abnormalities of quantities and functions of natural killer cells in severe aplastic anemia. Immunol Invest. 43(5):491–503.
   PubMed Web of Science ®Google Scholar
• Nocentini G, Alunno A, Petrillo MG, Bistoni O, Bartoloni E, Caterbi S, Ronchetti S, Migliorati G, Riccardi C, Gerli R, et al. 2014. Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients. Arthritis Res Ther. 16:444.
   PubMed Web of Science ®Google Scholar
• Rahmani F, Hadinedoushan HGhasemi H, Ghasemi N. 2019. Relative expression of OX40, OX40L mRNA, and OX40L serum levels in women with recurrent spontaneous abortion. Immunol Invest. 48(5):480–89.
   PubMed Web of Science ®Google Scholar
• Riccardi C, Ronchetti SNocentini G. 2018. Glucocorticoid-induced TNFR-related gene (GITR) as a therapeutic target for immunotherapy. Expert Opin Ther Targets. 22:783–97.
   PubMed Web of Science ®Google Scholar
• Risitano AM, Maciejewski JP, Green S, Plasilova M, Zeng W, Young NS. 2004. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet. 364:355–64.
   PubMed Web of Science ®Google Scholar
• Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD, Xia C, Chung CS, Ayala A, Atkinson MA, et al. 2007. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 110(10):3673–81.
   PubMed Web of Science ®Google Scholar
• Shen H, Wu N, Nanayakkara G, Fu H, Yang Q, Yang WY, Li A, Sun Y, Drummer IVC, Johnson C, et al. 2019. Co-signaling receptors regulate T-cell plasticity and immune tolerance. Front Biosci (Landmark Ed). 24:96–132.
   PubMed Web of Science ®Google Scholar
• So TIshii N. 2019. The TNF-TNFR family of co-signal molecules. Adv Exp Med Biol. 1189:53–84.
   PubMed Web of Science ®Google Scholar
• Spanier JA, Nashold FE, Nelson CD, Praska CE, Hayes CE. 2020. Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression. J Neuroimmunol. 338:577105.
   PubMed Web of Science ®Google Scholar
• Thiery J, Keefe D, Boulant S, Boucrot E, Walch M, Martinvalet D, Goping IS, Bleackley RC, Kirchhausen T, Lieberman J, et al. 2011. Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells. Nat Immunol. 12(8):770–77.
   PubMed Web of Science ®Google Scholar
• Tigue NJ, Bamber L, Andrews J, Ireland S, Hair J, Carter E, Sridharan S, Jovanović J, Rees DG, Springall JS, et al. 2017. MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential. Oncoimmunology. 6(3):e1280645.
   PubMed Web of Science ®Google Scholar
• Voskoboinik I, Whisstock JC, Trapani JA. 2015. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 15(6):388–400.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Inoue N, Watanabe M, Yamamoto M, Ozaki H, Hidaka Y, Iwatani Y. 2019. Increases of CD80 and CD86 expression on peripheral blood cells and their gene polymorphisms in autoimmune thyroid disease. Immunol Invest. 49:191–203.
   Web of Science ®Google Scholar
• Xiao ZX, Olsen NZ, Heng SG. 2019. The essential role of costimulatory molecules in systemic lupus erythematosus. Lupus. 28(5):575–82.
   PubMed Web of Science ®Google Scholar
• Xufre C, Costa M, Roura-Mir C, Codina-Busqueta E, Usero L, Pizarro E, Obiols G, Jaraquemada D, Martí M. 2013. Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients. Int Immunol. 25(10):563–74.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Watanabe M, Inoue N, Watanabe A, Ozaki H, Ohsaki M, Hidaka Y, Iwatani Y. 2020. Association of CD58 polymorphisms and its protein expression with the development and prognosis of autoimmune thyroid diseases. Immunol Invest. 49(1–2):106–19.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li X, Li B, Mu L, Wang J, Cheng Y, Gu Y, Wu H. 2020. Associations between TNFSF4 gene polymorphisms (rs2205960 G>A, rs704840 T>G and rs844648 G>A) and susceptibility to autoimmune diseases in Asians: a meta-analysis. Immunol Invest. 24:1–17.
   Google Scholar
• Young NS. 2018. Aplastic anemia. N Engl J Med. 379:1643–56.
   PubMed Web of Science ®Google Scholar
• Zhang MJ, Yang JL, Zhou J, Gao W, Zhang Y, Lin Y, Wang H, Ruan Z, Ni B. 2019a. Prognostic values of CD38+CD101+PD1+CD8+T cells in pancreatic cancer. Immunol Invest. 48(5):466–79.
   PubMed Web of Science ®Google Scholar
• Zhang R, Li H, Bai LF, Duan J. 2019b. Association between T-cell immunoglobulin and mucin domain 3 (TIM-3) genetic polymorphisms and susceptibility to autoimmune diseases. Immunol Invest. 48(6):563–76.
   PubMed Web of Science ®Google Scholar
• Zhao S, Zhang Y, Huang G, Luo W, Li Y, Xiao Y, Zhou M, Li Y, Lai J, Li Y, et al. 2019. Increased CD8+CD27+perforin+ T cells and decreased CD8+CD70+ T cells may be immune biomarkers for aplastic anemia severity. Blood Cell Mol Dis. 77:34–42.
   PubMed Web of Science ®Google Scholar
• Zhao WH, Zhang YL, Zhang PY, Yang J, Zhang L, He A, Zhang W, Hideto T. 2017. High programmed death 1 expression on T cells in aplastic anemia. Immunol Lett. 183:44–51.
   PubMed Web of Science ®Google Scholar